Skip to main content

Follow us

LinkedIn
Twitter

E-newsletters Login

Main navigation

Podcast
Events
IR TV
Reports and Research
Magazine

Keyword

Topics menu

Investor perspectives
Careers
ESG
Shareholder targeting & ID
Case studies
Corporate access
AI & Tech
Small cap
Activism, M&A
Reporting
Regulation
Sell side

More()

Subscription menu

Subscribe

Oxford Biomedica

Six-month review: Emily Holden of Oxford Biomedica

Article

Six-month review: Emily Holden of Oxford Biomedica

Sep 26, 2022

Subscribe to Oxford Biomedica

Most read

‘Blah blah blah, alphabet soup’: Alison Taylor, author and NYU professor on the problem with ESG

‘Blah blah blah, alphabet soup’: Alison Taylor, author and NYU professor on the problems with ESG

Donald Trump - photo: Library of Congress

Trump’s victory may not mean what you think it does for ESG disclosures

Interest rates and IR: What a rate reduction might mean for growth vs value stocks

Interest rates and IR: What a rate reduction might mean for growth vs value stocks

Lorne Gorber at the IR Magazine Awards - Canada 2018

‘One of the brightest minds in the IR world’: Remembering Lorne Gorber

Bitcoin on keyboard - photo: Jievani Weerasinghe

Shareholder targeting & ID

Institutional investors boost crypto holdings, finds survey

Sign up to get stories direct to your inbox

Stay informed and ahead on the latest trends and activities in the fast-moving world of investor relations by signing up for our popular newsletters today. Our weekly and monthly updates give you topical updates, expert analysis and comprehensive coverage of market changes, regulatory updates, IR trends and best practices, careers and much more.

Email:

Footer

Research
Events
- Awards
- Think tanks
- Webinars
- Forums
- Networking
About

Footer networks

IR TV

Follow us

LinkedIn
Twitter

Copyright IR Media Group Ltd. 1995 - 2024 All rights reserved.

Footer bottom

Privacy Policy
Cookies
Terms & Conditions